The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype-Reference-Cited by-同舟云学术

The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype

Published:2005-01-01 Issue:5 Volume:386 Page:
ISSN:1431-6730
Container-title:Biological Chemistry
language:
Short-container-title:

Author:

Dergunov Alexander D.,Novoselov Alexey V.,Visvikis Sophie,Siest Gerard,Yakushkin Vladimir V.,Tsibulsky Vladimir

Publisher

Walter de Gruyter GmbH

Subject

Clinical Biochemistry,Molecular Biology,Biochemistry

Link

https://www.degruyter.com/document/doi/10.1515/BC.2005.053/pdf

Reference55 articles.

1. Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2.

2. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects

3. The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein

4. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele.

5. Metabolic origins and clinical significance of LDL heterogeneity

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VLDL receptor gene therapy for reducing atherogenic lipoproteins;Molecular Metabolism;2023-03

2. Different Pathways of Cellular Cholesterol Efflux;Cell Biochemistry and Biophysics;2022-06-23

3. Interactions of different lipoproteins with supported phospholipid raft membrane (SPRM) patterns to understand similar in-vivo processes;Biochimica et Biophysica Acta (BBA) - Biomembranes;2021-03

4. Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with theAPOEp.Leu167del Mutation;Human Mutation;2012-10-11

5. Apolipoprotein E genotype as a most significant predictor of lipid response at lipid-lowering therapy: Mechanistic and clinical studies;Biomedicine & Pharmacotherapy;2011-12